XIAMEN YUGUANG RUICAI TRADING CO., LTD. – Trademark Portfolio

Entity Type: 99

XIAMEN YUGUANG RUICAI TRADING CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include STEPLIFY. The owner is based in XIAMEN.

ROOM 10, 403, NO. 2 ZHONGLING ROAD

HULI DISTRICT,

XIAMEN 361015 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

STEPLIFY
STEPLIFY
Registered 2025

Trademark Classifications

XIAMEN YUGUANG RUICAI TRADING CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does XIAMEN YUGUANG RUICAI TRADING CO., LTD. have?

XIAMEN YUGUANG RUICAI TRADING CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does XIAMEN YUGUANG RUICAI TRADING CO., LTD. file in?

XIAMEN YUGUANG RUICAI TRADING CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are XIAMEN YUGUANG RUICAI TRADING CO., LTD.'s most well-known trademarks?

XIAMEN YUGUANG RUICAI TRADING CO., LTD.'s registered trademark portfolio includes well-known marks such as STEPLIFY. These are among 1 currently registered trademark in the portfolio.

What is XIAMEN YUGUANG RUICAI TRADING CO., LTD.'s trademark registration success rate?

XIAMEN YUGUANG RUICAI TRADING CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.